Zimmer Biomet Holdings Inc Q1 2022 Earnings Call Summary - Thomson StreetEvents

Zimmer Biomet Holdings Inc Q1 2022 Earnings Call Summary

Zimmer Biomet Holdings Inc Q1 2022 Earnings Call Summary - Thomson StreetEvents
Zimmer Biomet Holdings Inc Q1 2022 Earnings Call Summary
Published May 03, 2022
20 pages (12638 words) — Published May 03, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of ZBH.N earnings conference call or presentation 3-May-22 12:30pm GMT

  
Brief Excerpt:

...A. Results: COVID Impacts: 1. a. Has strong qtr. above its own expectations and external expectations. Primary reason for that level of over achievement was stronger than anticipated COVID recovery., particularly when Co. looked at back half of the qtr. i. ii. US recovery was stronger and faster across the board, and while Co. continues to see COVID surges in EMEA and China, impact on overall procedure cancellations has been minimal at least so far. iii. Co. sees very strong performance in large joints, and in particular the knee franchise, while set recovery lagged, ZBH's core Recon business at this point. b. Knows its still early in the year, but based on what Co. saw in the qtr., and really current trends into 2Q, its confidence in 2022 growth has definitely increased, and as result, it is raising and tightening its full-year guidance. i. There are clearly number of headwinds that Co. is facing, supply challenges, inflation, Russia-Ukraine, but given the revenue dependence on elective...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Zimmer Biomet Holdings Inc
Ticker
ZBH.N
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Travis Lee Steed - Barclays Bank PLC, Research Division - Analyst : Congrats on the quarter. I appreciate the colors on the margin pressures, but I just want to make sure it's clear how we're thinking about how these pressures flow through to 2023. It sounds like 50 basis points of incremental pressure at this point. But also, curious if you have any offsets like pricing. It was kind of noticeable that you didn't put pricing in the press release this quarter for the first time. So curious how you're thinking about that.

Question: Travis Lee Steed - Barclays Bank PLC, Research Division - Analyst : Yes, I appreciate all that color. And Suky, one follow-up on China. I just want to make sure we're modeling that correctly. It sounds like it was 200 to 300 basis point headwind to total company organic growth this quarter, but that comes back in Q4. And if you just look at China volume with the shutdowns, I'd love to hear how that's playing out in Q2 and the recovery there from a volume perspective.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Great. Maybe, I could ask, the S.E.T. business was the slowest grower this quarter. It's 25% of sales and we don't get geographic breakout or segments there. I was hoping if you could walk us through sort of the different components and any geographic differences to point out? Just given that a lot of your competitors called out extremities and sports medicine as positives this quarter.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : And are you guys willing to give any ex China growth rates for extremities and trauma?

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Great. And maybe, just one quick follow-up for me. As you think about China, it's a country with the difficult pathways forward with the no COVID policy. I just want to make sure, are you assuming continued pressure from lockdowns through the rest of the year? Or are you assuming that it resolves in the near term?

Table Of Contents

Zimmer Biomet Holdings Inc at JPMorgan US All Stars Conference Transcript – 2022-09-20 – US$ 54.00 – Edited Transcript of ZBH.N presentation 20-Sep-22 1:00pm GMT

Zimmer Biomet Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript – 2022-09-12 – US$ 54.00 – Edited Transcript of ZBH.N presentation 12-Sep-22 2:30pm GMT

Zimmer Biomet Holdings Inc Q2 2022 Earnings Call Summary – 2022-08-02 – US$ 54.00 – Edited Brief of ZBH.N earnings conference call or presentation 2-Aug-22 12:30pm GMT

Zimmer Biomet Holdings Inc Q2 2022 Earnings Call Transcript – 2022-08-02 – US$ 54.00 – Edited Transcript of ZBH.N earnings conference call or presentation 2-Aug-22 12:30pm GMT

Zimmer Biomet Holdings Inc Q1 2022 Earnings Call Transcript – 2022-05-03 – US$ 54.00 – Edited Transcript of ZBH.N earnings conference call or presentation 3-May-22 12:30pm GMT

Zimmer Biomet Holdings Inc Q4 2021 Earnings Call Summary – 2022-02-07 – US$ 54.00 – Edited Brief of ZBH.N earnings conference call or presentation 7-Feb-22 1:30pm GMT

Zimmer Biomet Holdings Inc Q4 2021 Earnings Call Transcript – 2022-02-07 – US$ 54.00 – Edited Transcript of ZBH.N earnings conference call or presentation 7-Feb-22 1:30pm GMT

Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference Transcript – 2022-01-10 – US$ 54.00 – Edited Transcript of ZBH.N presentation 10-Jan-22 8:00pm GMT

Zimmer Biomet Holdings Inc at Evercore ISI HealthCONx Virtual Conference Transcript – 2021-12-02 – US$ 54.00 – Edited Transcript of ZBH.N presentation 2-Dec-21 6:00pm GMT

Zimmer Biomet Holdings Inc at Stifel Healthcare Conference (Virtual) Transcript – 2021-11-17 – US$ 54.00 – Edited Transcript of ZBH.N presentation 17-Nov-21 3:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Zimmer Biomet Holdings Inc Q1 2022 Earnings Call Summary" May 03, 2022. Alacra Store. May 15, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2022-Zimmer-Biomet-Holdings-Inc-Earnings-Call-B15171722>
  
APA:
Thomson StreetEvents. (2022). Zimmer Biomet Holdings Inc Q1 2022 Earnings Call Summary May 03, 2022. New York, NY: Alacra Store. Retrieved May 15, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2022-Zimmer-Biomet-Holdings-Inc-Earnings-Call-B15171722>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.